Microfluidic chip tracks cancer relapse by measuring white blood cell adhesion

Researchers at UNIST have developed a microfluidic diagnostic chip that measures white blood cell adhesion properties to detect cancer recurrence and assess chemotherapy effectiveness. Led by Professor Joo Hun Kang, the technology represents a novel approach to cancer monitoring using immune cell behavior. The innovation could transform how oncologists track disease relapse and treatment response.